“A Drug Before Its Time?” @PartnerTx #Leukine may improve #cancer outcomes and reduce toxicity. https://t.co/8Mj1v14qf3 Learn more about how the Leukine Access Program #LeAP is leaping borders to reach more patients. https://t.co/gCop4sn606 #patientacc
RT @GarbineLizeaga: Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time? https:/…
RT @FrontImmunol: New Research: Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its T…
New Research: Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?: Background Sargramostim [recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF)] was… https://t.co/FWTan